Skip to main content

Table 3 Kir4.1 and IL-1β immunoreactivity in patients with/without epilepsy and with/without levetiracetam use

From: Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β

IR score With epilepsy (n = 42) Without epilepsy (n = 31) With levetiracetam (n = 14 ) Without levetiracetam (n = 28)
Kir4.1 4.9 ± 0.36* 6.5 ± 0.37 6.8 ± 0.62** 4.5 ± 0.37
IL-1β 5.5 ± 0.49* 1.3 ± 0.17 3.9 ± 1.14** 6.3 ± 0.46
HLA-DR 5.8 ± 0.31* 3.6 ± 0.36 4.28 ± 0.15 5.2 ± 0.40
  1. Values represent the mean immunoreactive score (IR) ± SEM. *P <0.05: significant difference compared to patients without epilepsy; **P <0.05: significant difference compared to patients without levetiracetam use.